WEGE3.SA (WEGE3.SA)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 7.0.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency of WEGE3.SA demonstrates robust fundamental quality, anchored by a significant 18.1% spread between its 26.0% ROIC and 8.0% cost of capital, indicating strong value creation potential relative to financing costs. This return profile is primarily driven by operational leverage rather than financial engineering or margin expansion alone; while the firm maintains healthy profitability with net margins at 15.6%, the DuPont decomposition suggests that high gross margins of 33.5% are being leveraged effectively, though revenue growth remains moderate at 7.4%. Solvency and earnings stability appear secure given a Piotroski F-Score of 6/9 and an Altman Z-Score of 7.0, positioning the entity in a low-risk zone regarding bankruptcy probability while exhibiting solid financial strength relative to typical industry peers.
Valuation metrics present a divergence between current market pricing and intrinsic value models derived from discounted cash flow analysis. The stock trades at a forward P/E multiple of 32.1x, which implies significant growth expectations are already embedded in the share price; however, this premium appears elevated when contrasted against a DCF-derived fair value estimate of $47. Unless implied future growth rates exceed those required to justify the current multiple relative to the calculated intrinsic value, the market may be pricing in an aggressive expansion trajectory that has not yet been realized by the 7.4% year-over-year revenue increase observed recently.
No specific data regarding risk factor deltas, insider trading activity, or Fama-French alpha performance was provided for this analysis; consequently, a detailed assessment of idiosyncratic risks versus systematic market exposure cannot be synthesized from the available inputs. The investment case rests entirely on whether the company can accelerate revenue growth to align with its high ROIC capabilities and validate the premium valuation against the $47 fair value benchmark without relying solely on margin expansion or leverage increases.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 8% | 10% |
|---|---|---|---|
| 2% | $61 | $40 | $30 |
| 3% | $79 | $47 | $33 |
| 4% | $115 | $57 | $37 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $47 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
⚠️ Dividend consumes >80% of FCF — sustainability risk.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in WEGE3.SA to visualize passive redemption contagion across ETFs and collateral stocks.
If WEGE3.SA (WEGE3.SA) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vale SA (VALE3.SA) as the most exposed collateral stock, sharing 1 ETFs with WEGE3.SA. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
WEGE3.SA Ownership Dynamics
ETFs with Highest WEGE3.SA Exposure
Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
WEGE3.SA Capital Efficiency
How efficiently does WEGE3.SA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
WEGE3.SA converts 40% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 60% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 18.1% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare WEGE3.SA to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.